Re: Prostate Specific Antigen Density as a Predictor of Clinically Significant Prostate Cancer when the Prostate Specific Antigen is in the Diagnostic Gray Zone: .: A. Aminsharifi, L. Howard, Y. Wu, A. De Hoedt, C. Bailey, S. J. Freedland and T. J. Polascik J Urol 2018; 200: 758-766

J Urol. 2019 Mar;201(3):627-628. doi: 10.1016/j.juro.2018.09.063.

Authors

Chien-Sheng Wang¹, Jhen-Hao Jhan, Ching-Chia Li

Affiliation

¹ Department of Urology Graduate Institute of Medicine, Kaohsiung Medical University School of Medicine, No. 100, TzYou 1st Rd. Kaohsiung City 807, Taiwan.

PMID: 30759714
DOI: 10.1016/j.juro.2018.09.063

No abstract available

Publication types

Comment

MeSH terms

Body Mass Index
Humans
Male
Prostate-Specific Antigen*
Prostatic Neoplasms*
Racial Groups

Substances

Prostate-Specific Antigen